Inherent lipid metabolic dysfunction in glycogen storage disease IIIa.

•We report a new AGL mutation in a family severely affected by GSD III.•Glycogen storage diseases may give rise to a pathological acylcarnitine profile.•AGL mutation lead to an upregulation of genes encoding chemokines.•AGL mutation may affect PPAR and lipid/fatty acid biosynthesis signaling pathway.